Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study.
Diabetes Mellitus type 2
GLP-1 RA
GLS
Global Longitudinal Strain
Glucagone Like Peptide-1 Receptor Agonists
cardiac function
diabetic cardiomyopathy
dulaglutide
semaglutide
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
16 Feb 2023
16 Feb 2023
Historique:
received:
22
01
2023
revised:
08
02
2023
accepted:
14
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
(1) Background: Glucagone-Like Peptide-1 Receptor Agonists (GLP-1 RAs) (GLP-1 RAs) are incretine-based medications recommended in the treatment of type 2 Diabetes Mellitus (DM2) with atherosclerotic cardiovascular disease (ASCVD) or high or very high cardiovascular (CV) risk. However, knowledge of the direct mechanism of GLP-1 RAs on cardiac function is modest and not yet fully elucidated. Left ventricular (LV) Global Longitudinal Strain (GLS) with Speckle Tracking Echocardiography (STE) represents an innovative technique for the evaluation of myocardial contractility. (2) Methods: an observational, perspective, monocentric study was conducted in a cohort of 22 consecutive patients with DM2 and ASCVD or high/very high CV risk, enrolled between December 2019 and March 2020 and treated with GLP-1 RAs dulaglutide or semaglutide. The echocardiographic parameters of diastolic and systolic function were recorded at baseline and after six months of treatment. (3) Results: the mean age of the sample was 65 ± 10 years with a prevalence of the male sex (64%). A significant improvement in the LV GLS (mean difference: -1.4 ± 1.1%;
Identifiants
pubmed: 36836121
pii: jcm12041586
doi: 10.3390/jcm12041586
pmc: PMC9962489
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Diabetes Res. 2022 Apr 8;2022:4554996
pubmed: 35434139
Mol Metab. 2021 Apr;46:101102
pubmed: 33068776
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):260-274
pubmed: 29413646
Postgrad Med J. 2020 Mar;96(1133):156-161
pubmed: 31801807
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11
pubmed: 25525063
J Diabetes Investig. 2014 Nov;5(6):623-34
pubmed: 25422760
Circ Cardiovasc Interv. 2012 Apr;5(2):288-95
pubmed: 22496084
Int J Biol Sci. 2021 May 11;17(8):2050-2068
pubmed: 34131405
Echocardiography. 2014 Apr;31(4):456-63
pubmed: 24134395
Cardiovasc Diabetol. 2018 Jan 8;17(1):8
pubmed: 29310645
Eur Radiol. 2011 May;21(5):944-53
pubmed: 21063711
J Card Fail. 2006 Dec;12(9):694-9
pubmed: 17174230
Diabetologia. 2020 Sep;63(9):1718-1735
pubmed: 32632526
Basic Res Cardiol. 2020 Nov 30;115(6):74
pubmed: 33258101
Life Sci. 2013 Mar 28;92(11):601-8
pubmed: 23147391
Diabetes Metab. 2003 Nov;29(5):455-66
pubmed: 14631322
Circulation. 2019 Apr 23;139(17):2022-2031
pubmed: 30786725
Circ Res. 2014 May 23;114(11):1788-803
pubmed: 24855202
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
JAMA Cardiol. 2019 Oct 1;4(10):1007-1018
pubmed: 31433450
Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1361-72
pubmed: 21278133
Heart. 2015 Jul;101(13):1061-6
pubmed: 25935767
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
JACC Cardiovasc Imaging. 2016 Feb;9(2):176-92
pubmed: 26846937
Heart. 2012 Oct;98(19):1442-8
pubmed: 22865865
Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4648-4656
pubmed: 30058704
Eur J Clin Invest. 2021 Apr;51(4):e13475
pubmed: 33326612
Diabetes Care. 1994 Jul;17(7):633-9
pubmed: 7924771
Circulation. 2008 Apr 15;117(15):1945-54
pubmed: 18378618
Circ Cardiovasc Imaging. 2016 Dec;9(12):
pubmed: 27940956
Diabetes Obes Metab. 2017 Apr;19(4):524-536
pubmed: 27981757
Eur J Prev Cardiol. 2022 May 5;29(5):e173-e177
pubmed: 34499711
Eur Heart J Open. 2022 Feb 25;2(2):oeac010
pubmed: 35919124
N Engl J Med. 1998 Jul 23;339(4):229-34
pubmed: 9673301
Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):1049-1056
pubmed: 27742738
Endocrine. 2017 Sep;57(3):464-473
pubmed: 27830456
Endocrinol Metab (Seoul). 2019 Jun;34(2):106-116
pubmed: 31099200
Pflugers Arch. 2022 Jan;474(1):33-61
pubmed: 34978597
Radiol Med. 2021 Sep;126(9):1236-1248
pubmed: 34160775
Cardiovasc Diabetol. 2020 Jan 22;19(1):10
pubmed: 31969144
Herz. 2015 May;40 Suppl 3:240-6
pubmed: 25205476
Postgrad Med. 2020 Nov;132(sup2):3-14
pubmed: 32815454
Clin Cardiol. 2018 Jun;41(6):769-777
pubmed: 29604092
Lancet. 2019 Jul 13;394(10193):121-130
pubmed: 31189511
Rev Clin Esp (Barc). 2022 Feb;222(2):100-111
pubmed: 35115137
J Diabetes Res. 2021 Mar 27;2021:8838026
pubmed: 33855087
Am J Cardiol. 2009 Nov 15;104(10):1398-401
pubmed: 19892057
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E630-43
pubmed: 25117407
Endocr Rev. 2004 Aug;25(4):543-67
pubmed: 15294881
Heart Fail Clin. 2019 Jul;15(3):341-347
pubmed: 31079692
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Diabetes Obes Metab. 2013 Aug;15(8):737-49
pubmed: 23433305
Br J Pharmacol. 2022 Feb;179(4):659-676
pubmed: 33764504
Circulation. 2017 Aug 29;136(9):849-870
pubmed: 28847797
J Surg Res. 2011 Jan;165(1):38-45
pubmed: 19552923
Diabetol Metab Syndr. 2016 Jan 12;8:5
pubmed: 26759609
Cardiovasc Diabetol. 2019 Apr 30;18(1):55
pubmed: 31039778